Year archive

Duality Biotherapeutics, Inc. — 2025 filings

All 46 regulatory filings released by Duality Biotherapeutics, Inc. (9606) in 2025, sourced directly from the official regulator.

46 Filings

2025 Period

2025 filings (46)

Filing	Released	Lang
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 30, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-12-30	English
2025 SHARE SCHEME Regulatory Filings	2025-12-14	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 30, 2025 Proxy Solicitation & Information Statement	2025-12-14	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-12-14	English
(1) PROPOSED ADOPTION OF THE 2025 SHARE SCHEME; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-12-14	English
PROPOSED ADOPTION OF THE 2025 SHARE SCHEME Share Issue/Capital Change	2025-12-14	English
BOOK CLOSURE PERIOD FOR THE EXTRAORDINARY GENERAL MEETING Regulatory Filings	2025-12-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Share Issue/Capital Change	2025-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Share Issue/Capital Change	2025-11-05	English
INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE Share Issue/Capital Change	2025-10-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-08	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-17	English
VOLUNTARY ANNOUNCEMENT - INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX AND INCLUSION IN THE STOCK LIST OF STOCK CONNECT SOUTHBOUND TRADING LINK Regulatory Filings	2025-09-07	English
INSIDE INFORMATION - PRIMARY ENDPOINT MET FOR PHASE III CLINICAL TRIAL OF DB-1303/BNT323 IN PATIENTS WITH HER2-POSITIVE UNRESECTABLE OR METASTATIC BREAST CANCER Regulatory Filings	2025-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-03	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-26	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-06	English
VOLUNTARY ANNOUNCEMENT - KEY PRODUCT DB-1310 GRANTED U.S. FDA FAST TRACK DESIGNATION Regulatory Filings	2025-07-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-07	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-20	English
ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES Regulatory Filings	2025-06-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-05	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 20, 2025 Proxy Solicitation & Information Statement	2025-05-28	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2025-05-28	English
(1) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE SHARES; (2) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES (INCLUDING SALE OR TRANSFER OF TREASURY SHARES); (3) PROPOSED RE-ELECT Proxy Solicitation & Information Statement	2025-05-28	English
STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Capital/Financing Update	2025-05-12	English
Next Day Disclosure Return Share Issue/Capital Change	2025-05-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-08	English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION Share Issue/Capital Change	2025-05-06	English
2024 Environmental, Social and Governance Report Environmental & Social Information	2025-04-29	English
EXEMPTION UNDER RULE 13.46(2) OF THE LISTING RULES REGARDING 2024 ANNUAL REPORT Report Publication Announcement	2025-04-29	English
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Share Issue/Capital Change	2025-04-14	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-04-14	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE Governance Information	2025-04-14	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE Governance Information	2025-04-14	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE Governance Information	2025-04-14	English
MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2025-04-14	English
Documents on Display Regulatory Filings	2025-04-07	English
GLOBAL OFFERING Regulatory Filings	2025-04-07	English
GLOBAL OFFERING Share Issue/Capital Change	2025-04-07	English
PHIP (1st submission) Capital/Financing Update	2025-03-23	English
PHIP (1st submission) Regulatory Filings	2025-03-23	English
OC Announcement - Appointment Regulatory Filings	2025-02-27	English
Application Proof (1st submission) Report Publication Announcement	2025-02-27	English
Application Proof (1st submission) Regulatory Filings	2025-02-27	English